Articles about Product Safety

Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit Against Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is November 2, 2026

Today 10:10 EDT

Grail Stock Has Soared 180% in 6 Months. Here's Why the Stock Has More Room to Run. ↗

Today 8:20 EDT

Kaplan Fox Alerts Investors to an Upcoming Deadline of November 3, 2026 in the Beta Bionics, Inc. (NASDAQ: BBNX) Securities Class Action

Why Grail Stock Skyrocketed Nearly 70% In A Week. What To Watch Next. ↗

Today 8:00 EDT

Via Investor's Business Daily

Naugatuck, CT Author Explores Identity, Representation, and Black Experience

Today 3:00 EDT

Via PR Leap

September 29, 2026

Kaplan Fox is Investigating Medline Inc. (NASDAQ: MDLN) for Potential Securities Law Violations - Investors Encouraged to Contact the Firm

September 29, 2026

Kaplan Fox Encourages Investors of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Who Suffered Losses to Contact the Firm

September 29, 2026

Unicycive Therapeutics Announces Resubmission of New Drug Application for Oxylanthanum Carbonate

September 29, 2026

Via B2i Digital

Neogen (NEOG) Stock Trades Down, Here Is Why

September 29, 2026

Via StockStory

Aldeyra to Appeal FDA Rejection of Reproxalap for Dry Eye Disease ↗

September 29, 2026

Inventiva (IVA) Q2 2026 Earnings Call Transcript ↗

September 29, 2026

Kaplan Fox Alerts Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Seek Leadership in a Securities Fraud Lawsuit by November 3, 2026

September 29, 2026

ReposiTrak (TRAK) Q4 2026 Earnings Call Transcript ↗

September 29, 2026

Kaplan Fox & Kilsheimer LLP Alerts Beta Bionics, Inc. (NASDAQ: BBNX) Investors to the Lead Plaintiff Deadline on November 3, 2026

VivoSim Labs Inc. (NASDAQ: VIVS) Targets the Multibillion-Dollar Cost of Failed Drugs

September 28, 2026

Via AB Newswire

September 28, 2026

ReposiTrak Q4 Earnings Call Highlights ↗

September 28, 2026

Robbins LLP is Investigating Allegations that Replimune Group, Inc. Misled Investors Regarding the Efficacy and Viability of its Lead Product Candidate RP1

RIXA Recovery and Performance Announces Grand Opening of New Perrysburg Location

September 28, 2026

Via Press Advantage

September 28, 2026

Via Newsfile

DreaMed Receives FDA Clearance for MODI, Bringing Automated Insulin Dose Recommendations to People with Type 2 Diabetes Using Injections

September 28, 2026

Via Newsfile

Kaplan Fox Deadline Alert: Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors Have Until November 2, 2026 to Seek a Lead Plaintiff Role

September 28, 2026

Xenon Files Azetukalner NDA as It Pauses Psychiatry Trials for Tolerability Review ↗

September 27, 2026

Here's Exactly Why Wall Street Thinks Argenx Stock Could Soar 23% Over the Next 12 Months ↗

BeautySnob Launches Market-Specific Ingredient Safety Scores for Beauty Products

September 27, 2026

Via Press Release Distribution Service

September 26, 2026

BridgeBio Pharma Eyes Four Global Launches by 2027 as Attruby Nears Blockbuster Status ↗

September 26, 2026

Kaplan Fox & Kilsheimer LLP Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before November 3, 2026

September 25, 2026

Woman-Owned NuYOU360 Prices FDA Cleared Red Light Therapy Masks From $289, Built on the Founder’s Own Decade of Daily Use

September 25, 2026

Via AB Newswire

Kaplan Fox Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026

September 25, 2026

TechMediaBreaks – SS Innovations International Inc. (NASDAQ: SSII) Eyes Growing Opportunity for Surgical Robotics

September 25, 2026

Via Investor Brand Network

Kaplan Fox Reminds Investors of Medline Inc. (NASDAQ: MDLN) of an Ongoing Investigation into Potential Securities Law Violations

September 25, 2026